Skip to content

    Xtant Medical Holdings (XTNT) stock price & financials

    View XTNT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance37.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $27.94M
    $31.51M
    $32.90M
    $35.41M
    $33.26M
    +19.0%
    $32.36M
    +2.7%
    $20.88M
    -36.5%
    $23.03M
    -35.0%
    Weakening
    Operating Profit
    -$3.78M
    -$1.88M
    $1.06M
    $4.62M
    $2.54M
    -$944.0K
    +49.8%
    -$2.92M
    -375.0%
    -$9.17M
    -298.3%
    Weakening
    Net Profit
    -$5.02M
    -$3.16M
    $58.0K
    $3.55M
    $1.31M
    $57.0K
    -$3.09M
    -5425.9%
    -$9.41M
    -365.2%
    Weakening
    EPS
    $-0.04
    $0.00
    $0.03
    $0.01
    $-0.02
    $-0.07
    -333.3%
    Weakening
    Other Income
    -$1.19M
    -$1.26M
    -$1.03M
    -$819.0K
    -$976.0K
    +17.6%
    $2.54M
    -$139.0K
    +86.5%
    -$171.0K
    +79.1%
    Strengthening
    Interest
    $1.20M
    $1.13M
    $1.04M
    $1.00M
    $904.0K
    -24.6%
    $718.0K
    -36.7%
    $599.0K
    -42.7%
    $542.0K
    -46.0%
    Weakening
    Depreciation
    Profit before Tax
    -$4.96M
    -$3.14M
    $33.0K
    $3.81M
    $1.56M
    $1.60M
    -$3.06M
    -9378.8%
    -$9.34M
    -345.5%
    Weakening
    MarginsOPM
    -13.5%
    -6.0%
    3.2%
    13.1%
    7.6%
    -2.9%
    +51.1%
    -14.0%
    -533.4%
    -39.8%
    -404.8%
    Weakening
    Tax
    -1.3%
    -0.7%
    -75.8%
    6.7%
    16.4%
    96.4%
    -0.9%
    +98.8%
    -0.8%
    -111.6%
    Weakening
    ReturnsROIC
    1.9%
    1.2%
    -0.0%
    -1.3%
    -0.5%
    -126.0%
    -0.0%
    -101.8%
    1.2%
    3.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$6.80M$5.24M$2.34M$18.24M$20.30M$5.71M$6.20M$17.05M$9.87M
    Short-Term Investments
    Total Current Assets$34.68M$32.25M$31.36M$44.33M$49.32M$64.87M$67.12M$78.25M$64.78M
    Net PP&E$10.17M$6.79M$6.04M$6.47M$7.17M$10.21M$10.96M$9.39M$8.44M
    Goodwill$3.21M$3.21M$3.21M$3.21M$3.21M$7.30M$7.30M$6.07M$6.07M
    Intangibles$573.0K$515.0K$457.0K$400.0K$344.0K$10.09M$8.36M$299.0K$252.0K
    Total Assets$46.42M$43.16M$41.47M$54.69M$60.23M$92.61M$93.84M$94.14M$79.67M
    LiabilitiesTotal Current Liabilities$12.05M$9.39M$25.65M$11.08M$15.22M$22.99M$28.58M$29.48M$29.96M
    Short-Term Debt$16.80M$2.33M$3.50M$3.72M
    Long-Term Debt$77.94M$76.24M$11.79M$9.69M$17.17M$22.04M$11.03M$7.29M
    Long-Term Leases$1.73M$1.30M$842.0K$972.0K$759.0K$166.0K$2.67M$2.40M
    Total Liabilities$90.19M$87.36M$26.95M$23.81M$26.06M$41.26M$50.87M$43.19M$39.65M
    EquityCommon Stock & APIC$0
    Retained Earnings-$215.04M-$223.27M-$230.34M-$235.19M-$243.67M-$243.01M-$259.46M-$254.49M-$266.99M
    Total Equity-$43.77M-$44.20M$14.51M$30.88M$34.17M$51.35M$42.96M$50.95M$40.02M
    HighlightsNet Cash / (Debt)$8.28M$2.53M-$1.14M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$1.21M-$413.0K-$731.0K$439.0K-$5.34M-$9.52M-$11.90M$12.55M$570.0K
    Cash from Investing-$367.0K-$544.0K-$1.30M-$1.89M-$1.56M-$24.78M-$3.73M$7.90M$14.39M
    Cash from Financing$3.10M-$603.0K-$861.0K$17.50M$9.02M$19.69M$16.07M-$9.57M-$12.03M
    SummaryCapital Expenditure-$624.0K-$879.0K-$1.54M-$2.12M-$1.76M-$1.46M-$4.11M-$2.38M-$1.27M
    Free Cash Flow$588.0K-$1.29M-$2.28M-$1.68M-$7.11M-$10.97M-$16.01M$10.16M-$696.0K
    FCF Margin0.8%-2.0%-4.3%-3.0%-12.3%-12.0%-13.7%7.6%-0.6%

    Ratios